Yoko Mizoguchi

1.2k total citations
35 papers, 327 citations indexed

About

Yoko Mizoguchi is a scholar working on Immunology, Hematology and Infectious Diseases. According to data from OpenAlex, Yoko Mizoguchi has authored 35 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 9 papers in Hematology and 8 papers in Infectious Diseases. Recurrent topics in Yoko Mizoguchi's work include Immunodeficiency and Autoimmune Disorders (13 papers), Blood disorders and treatments (7 papers) and Hemophilia Treatment and Research (6 papers). Yoko Mizoguchi is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (13 papers), Blood disorders and treatments (7 papers) and Hemophilia Treatment and Research (6 papers). Yoko Mizoguchi collaborates with scholars based in Japan, United States and France. Yoko Mizoguchi's co-authors include Satoshi Okada, Masao Kobayashi, Miyuki Tsumura, Kazuhiro Nakamura, Y Horiuchi, Kiyoaki Tanimoto, Shinichiro Miyagawa, Reiko Kagawa, Shiho Nishimura and Teruyuki Kajiume and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Journal of Allergy and Clinical Immunology.

In The Last Decade

Yoko Mizoguchi

29 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoko Mizoguchi Japan 12 158 72 70 68 64 35 327
Irena Zentsová Czechia 11 223 1.4× 77 1.1× 39 0.6× 91 1.3× 66 1.0× 19 374
Afroditi Boulougoura United States 10 169 1.1× 30 0.4× 71 1.0× 50 0.7× 77 1.2× 20 372
Aleksandra Szczawińska-Popłonyk Poland 11 184 1.2× 95 1.3× 55 0.8× 36 0.5× 72 1.1× 47 343
Sheila Waugh United Kingdom 8 147 0.9× 29 0.4× 103 1.5× 42 0.6× 44 0.7× 17 358
Chul‐Woo Pyo United States 12 262 1.7× 112 1.6× 55 0.8× 34 0.5× 46 0.7× 34 467
Wenjing Ying China 12 266 1.7× 77 1.1× 79 1.1× 88 1.3× 58 0.9× 35 378
Willianne Hoepel Netherlands 11 182 1.2× 24 0.3× 36 0.5× 71 1.0× 79 1.2× 15 343
Thomas Hägglöf United States 11 314 2.0× 38 0.5× 63 0.9× 90 1.3× 138 2.2× 17 492
Bandar Al‐Saud Saudi Arabia 15 320 2.0× 136 1.9× 99 1.4× 44 0.6× 91 1.4× 37 493
Sarah Casulli France 11 168 1.1× 34 0.5× 61 0.9× 28 0.4× 113 1.8× 11 398

Countries citing papers authored by Yoko Mizoguchi

Since Specialization
Citations

This map shows the geographic impact of Yoko Mizoguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoko Mizoguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoko Mizoguchi more than expected).

Fields of papers citing papers by Yoko Mizoguchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoko Mizoguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoko Mizoguchi. The network helps show where Yoko Mizoguchi may publish in the future.

Co-authorship network of co-authors of Yoko Mizoguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Yoko Mizoguchi. A scholar is included among the top collaborators of Yoko Mizoguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoko Mizoguchi. Yoko Mizoguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tanaka, Mari, et al.. (2024). A Pediatric Case of B Cell Precursor ALL With Blinatumomab-associated Encephalopathy. Journal of Pediatric Hematology/Oncology. 46(7). e550–e555.
2.
Tsumura, Miyuki, Masato Yashiro, Zenichiro Kato, et al.. (2024). Exclusive Characteristics of the p.E555K Dominant-Negative Variant in Autosomal Dominant E47 Deficiency. Journal of Clinical Immunology. 44(7). 167–167.
3.
Tsumura, Miyuki, Tina Nguyen, Takaki Asano, et al.. (2023). Isolated Chronic Mucocutaneous Candidiasis due to a Novel Duplication Variant of IL17RC. Journal of Clinical Immunology. 44(1). 18–18. 3 indexed citations
4.
Mizoguchi, Yoko, Shiho Nishimura, Hiroshi Kawaguchi, et al.. (2023). Age‐specific incidence of joint disease in paediatric patients with haemophilia: A single‐centre real‐world outcome based on consecutive US examination. Haemophilia. 29(5). 1359–1365. 1 indexed citations
5.
Fan, Yanxin, Yoko Mizoguchi, Megumi Tatematsu, et al.. (2023). Analyzing mitochondrial respiration of human induced pluripotent stem cell-derived myeloid progenitors using Seahorse technology. STAR Protocols. 4(1). 102073–102073.
7.
Mizoguchi, Yoko, et al.. (2022). Mendelian susceptibility to mycobacterial diseases: state of the art. Clinical Microbiology and Infection. 28(11). 1429–1434. 20 indexed citations
8.
Tsumura, Miyuki, Yoko Mizoguchi, Osamu Hirata, et al.. (2021). Enhanced osteoclastogenesis in patients with MSMD due to impaired response to IFN-γ. Journal of Allergy and Clinical Immunology. 149(1). 252–261.e6. 16 indexed citations
9.
Ziętara, Natalia, Marcin Łyszkiewicz, Yoko Mizoguchi, et al.. (2020). Mammalian VPS45 orchestrates trafficking through the endosomal system. Blood. 137(14). 1932–1944. 15 indexed citations
10.
Mizoguchi, Yoko, et al.. (2018). A Synbiotic with Tumor Necrosis Factor-αInhibitory Activity Ameliorates Experimental Jejunoileal Mucosal Injury. BioMed Research International. 2018. 1–12. 5 indexed citations
11.
Nishimura, Shiho, et al.. (2017). Pharmacokinetics Using myPKFiTR for Personalized Prophylaxis in Children with Severe Hemophilia a.. Blood. 130. 2361–2361. 1 indexed citations
12.
Ebihara, Yasuhiro, Yoko Mizoguchi, Kazuhiro Nakamura, et al.. (2013). Wnt3a stimulates maturation of impaired neutrophils developed from severe congenital neutropenia patient-derived pluripotent stem cells. Proceedings of the National Academy of Sciences. 110(8). 3023–3028. 29 indexed citations
13.
Ebihara, Yasuhiro, Yoko Mizoguchi, Kazuhiro Nakamura, et al.. (2011). Suppressed Neutrophil Development in Hematopoiesis of Induced Pluripotent Stem Cells Derived From a Severe Congenital Neutropenia Patient with ELA2 Mutation. Blood. 118(21). 730–730. 1 indexed citations
14.
Okada, Satoshi, Miyuki Tsumura, Yoko Mizoguchi, et al.. (2011). Decreased Expression in Nuclear Factor-κB Essential Modulator Due to a Novel Splice-Site Mutation Causes X-linked Ectodermal Dysplasia with Immunodeficiency. Journal of Clinical Immunology. 31(5). 762–772. 2 indexed citations
15.
Ishikawa, Nobutsune, et al.. (2011). A Case of Neonatal Coxsackie B2 Meningo-Encephalitis in which Serial Magnetic Resonance Imaging Findings Reveal the Development of Lesions. Neuropediatrics. 42(4). 156–158. 9 indexed citations
16.
Mizoguchi, Yoko, et al.. (2010). Significance of immature platelet fraction and CD41-positive cells at birth in early onset neonatal thrombocytopenia. International Journal of Hematology. 91(2). 245–251. 6 indexed citations
17.
Mizoguchi, Yoko, Naoto Fujita, Tomohiko Taki, Yasuhide Hayashi, & Kazuko Hamamoto. (2009). Juvenile myelomonocytic leukemia with t(7;11)(p15;p15) and NUP98‐HOXA11 fusion. American Journal of Hematology. 84(5). 295–297. 11 indexed citations
18.
Nakamura, Kazuhiro, et al.. (2009). Deficiency of regulatory T cells in children with autoimmune neutropenia. British Journal of Haematology. 145(5). 642–647. 16 indexed citations
19.
Mizoguchi, Yoko, Kazuhiro Nakamura, Shinichiro Miyagawa, et al.. (2005). A Case of Adolescent Primary Adrenal Natural Killer Cell Lymphoma. International Journal of Hematology. 81(4). 330–334. 12 indexed citations
20.
Mizoguchi, Yoko, et al.. (1979). Immune receptors (IgG-Fc and complement receptors) in normal human organs.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 40(6). 703–7. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026